Elevated levels of IL-6 in patients with HCC activate the STAT3/C-Myc pathway to increase the transcript levels of miR-25-3p in TAMs, resulting in inhibition of phosphatase receptor type O. This inhibition increases the expression of PD-L1, which in turn causes T cell exhaustion [237]. Here, IL6 is linked to hepatocellular carcinoma.